Terns Pharmaceuticals, Inc. (TERN)

34.33 -1.64 (-4.56%) USD  |  NASDAQ  |  Jan 23, 16:00
34.36 +0.04 (+0.10%) Pre-Market: 20:00
More

Terns Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for TERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Altimmune, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade